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In most operating and recovery rooms, shivering is controlled by the use of humidifiers, 
warming blankets, and inhalation of humidified heated oxygen. However, pharmacological control is an 
effective alternative treatment modality. This study was designed to compare the efficacy of tramadol 
versus meperidine in the treatment of shivering after spinal anesthesia. 
In a double-blind randomized clinical trial, we studied 70 obstetric patients with ASA class I or 
II who had shivering following spinal anesthesia (SA) with 0.5% bupivacaine. All patients were randomly 
allocated to one of the two groups receiving tramadol 0.5 mg/kg (group T, n = 35), or meperidine 0.5 
mg/kg (group M, n = 35). The onset of cessation of shivering, the efficacy of agents for treatment of 
shivering, hemodynamic variables, sedation score, pruritus, nausea and vomiting were assessed. 
 Shivering ceased after 2.57±2.26 and 6.24±4.76 minutes in group T and group M respectively 
(p=0. 03). The differences before and after injection of meperidine for the heart rate, respiratory rate and 
arterial oxygen saturation were significant (p<0.001). Nausea and vomiting occurred significantly more 
frequently in the meperidine group compared to the tramadol group (p<0.001).  
Tramadol is a more effective agent than meperidine in the treatment of post spinal shivering, 
with lower early side effects in obstetric patients. 
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hivering is an unpleasant and frequent complication in 
the postoperative period [1]. It may interfere with 
monitoring of electrocardiogram, blood pressure, and 
pulse oximetry [2]. In patients with post anesthesia 
shivering, left ventricular systolic work index is increased 
and oxygen consumption may be increased by 200% to 
500% [3]. Thus, in patients with decreased myocardial 
reserve, shivering may further compromise myocardial 
function. Shivering may also increase intraocular and 
intracranial pressures, and may also contribute to increased 
wound pain [4]. The possible mechanisms of shivering after 
spinal anesthesia in parturients result from central 
thermoregulation disturbance [5]. Shivering may be justified 
as a thermoregulatory response to hypothermia that occurs 
during operation and presents with tonic or clonic patterns 
[6]. Equipment to maintain normothermia is effective in 
preventing shivering, but may be expensive and is not 
practical in all settings [7]. Pharmacological agents remain 
the most popular mode of treatment for shivering. Many 
agents have been used to eliminate postoperative shivering 
such as meperidine, doxapram, tramadol, ketanserin, 
clonidine, propofol, physostigmine and nefopam, 
dexamethasone, magnesium sulfate, and fentanyl [8-10]. 
Among the opioids, mepridine has been found to be the most 
efficacious. Meperidine controlled shivering better than 
equal analgesic doses of other pure µ-opioid agonists such as 
fentanyl, alfentanil, sufentanil, or morphine, and unlike them 
the antishivering effects of meperidine were reversed by 
large-doses of naloxone [11]. Accordingly, the antishivering 
effect of meperidine may be mediated in part by activation 
of none µ-opioid receptors. However, meperidine probably 
acts directly on the thermoregulatory center [12]. 
Disadvantages of meperidine are excessive sedation, 
respiratory depression and postoperative nausea and 
vomiting, which may be induced with previously 
administered opioids or anesthetics. Tramadol is effective in 
the treatment of postanesthetic shivering [12]. Tramadol 
producees weak sedation effect and present low respiratory 
depression, thus, it can be used safely in parturients [13]. It 
was shown that tramadol inhibits the neuronal reuptake of 
norepinephrine and 5-hydroxytrypamine, facilitates 5-
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[14]. Each of these actions is likely to influence the 
thermoregulatory control [15]. However, tramadol had only 
slight thermoregulatory effect and thus, it is unlikely to 
provoke hypothermia [16]. The main opioid effect of 
tramadol is mediated via the µ receptor [17]. Moreover, the 
antinociceptive effects of tramadol were significantly 
decreased by α2-adrenoceptor antagonists [18]. Also, it was 
identified that tramadol is similar to clonidine, a partial α2-
adrenoceptor agonist and could be useful in the treatment of 
postoperative shivering [19]. Delaunay showed that 
clonidine reduced the thermoregulatory thresholds for both 
vasoconstriction and shivering [19]. Tramadol may induce 
its antishivering effects via both-opioid receptor and α2-
adrenergic agonist mechanisms. The interaction of opioid 
and α2-adrenoceptor mechanisms working in a 
complementary or synergistic manner and produce 
antishivering effects [20]. Recent studies have investigated 
the efficacy of tramadol in the management of perioperative 
of shivering [21]. Some of the studies have shown that 
tramadol was better than meperidine for treatment of 
perioperative shivering [22-23]. The aim of this study was to 
compare the anti-shivering effects and the accompanying 
early side effects of tramadol and meperidine after spinal 
anesthesia in parturients. 
Methods 
In a double blind, randomized clinical trial with approval 
of ethic committee of our hospital and informed written 
consent, we studied 70 obstetric patients with ASA physical 
status I-II who were candidates for elective cesarean section 
and developed shivering following spinal anesthesia. The 
severity of shivering was graded on a scale of 0 to 4 that had 
been validated by Crossley and Mahajan [24] (zero = no 
shivering, 1= peripheral vasoconstriction, but no visible 
shivering, 2 = muscular activity in only one muscle group, 3 
= muscular activity in more than one muscle group but not 
generalized shivering, 4 = shivering involving the whole 
body). Only parturients who developed Grade 3 or 4 
shivering for at least 3 min were included. The exclusion 
criteria were hyperthyroidism, cardiopulmonary disease, 
hemodynamic instability, patients with ASA class 3 or 4 and 
a known history of alcohol or substance abuse. The 
temperature of the operating room was maintained at 23°C. 
Standard monitoring, including continuous ECG, heart rate, 
non-invasive arterial blood pressure, and continuous pulse 
oximetry (Novin S1800, Iran) was used during surgery. All 
patients recived preloading with 5 ml/kg ringer lactate and 
then underwent spinal anesthesia with the midline approach 
at the L3-L4 interspace using a 27-Gauge spinal needle. 
After free CSF flow had been observed, 10 mg hyperbaric 
bupivacaine 0.5% (Marcaine Spinal Heavy, Astra, Sweden) 
was injected through the needle. Then, patients were 
immediately turned to supine. Hypotension was defined as a 
systolic blood pressure less than 90 mmHg or a decrease of 
more than 25% from the baseline of mean arterial pressure at 
the first 30 min after spinal anesthesia. The hypotension 
episodes were treated with a loading dose of intravenous 
fluids and an intravenous bolus of ephedrine 5–10 mg. Of 
the 70 parturients who shivered after spinal anesthesia and 
requested anti-shivering treatment were assigned randomly 
according to a computer generated random number table to 
two groups; group T (n = 35) who received 0.5 mg/kg 
tramadol hydrochloride and group M (n = 35) that received 
0.5 mg/kg meperidine. The dosage of tramadol and 
meperidine was chosen according to previous studies [25]. 
Our surgeons, anesthesiologists and research physicians 
were unaware of the allocation of the study participants. 
Drug efficacy was assessed on the basis of a sustained 
decrease in the grade of shivering. The perioperative side-
effects, including changes in hemodynamic status, sedation 
score based on the Ramsay Sedation Scale, pruritus, nausea 
and vomiting were assessed. Statistical analysis was 
performed with the software SPSS. Nonparametric data were 
analyzed using the t-test. Categorical data were analyzed 
using the χ2 test. Values are reported as mean ± SD. A p-
value of <0.05 was considered statistically significant. 
Results 
The baseline characteristics and clinical data were 
comparable between the two groups (Table1). None of our 
cases in both groups were excluded during our study. The 
shivering ceased 2.57±2.26 minutes and 6.24±4.76 minutes 
after administration of tramadol and meperidine respectively 
(p=0. 03). The efficacy of anti-shivering effect was not 
statistically different between two groups (91.4% and 82.8% 
after 5 minutes of spinal anesthesia and 97.1% and 88.5% 
after 10 minutes of spinal anesthesia in tramadol and 
meperidine group respectively (p=0. 34). Sedation score 
within 30 minutes was similar for both groups (p=0. 051). 
Moreover, there were no significant differences in systolic 
(p=0. 28) and diastolic (p=0. 28) blood pressures 5, 10 and 
30 minutes after spinal anesthesia between the two groups. 
However, there was a significant difference in heart rate 
(p<0.001), arterial oxygen saturation (p<0.001) and 
respiratory rate (p<0.001) within 30 minutes after spinal 
anesthesia between the two groups. Nausea and vomiting 
occurred significantly more frequent in the meperidine 
group compared to the other group (p<0.001), but pruritus 
was not significantly different between the two groups (p=0. 
51) (Table 2). 
Discussion 
The results of this study support the results of other studies 
indicating that tramadol is effective in the treatment of 
postanaesthetic shivering, and show that the time of an end 
of shivering is significantly earlier than after meperidine 
administration. The efficacy of tramadol in the treatment of 
shivering after spinal anesthesia in this study was similar to 
the results of previous studies [15]. In a double blind, 
randomized clinical trial study of pregnant women who were 
candidates for elective caesarean section, it was shown that 
the control of shivering with tramadol was better than 
meperidine like in our study [22, 26-31]. In another study, 
ceasing of shivering after tramadol was faster than 
meperidine, and also with fewer side effects [7]. Also, 
Bhattacharya reported that the tramadol was better than 
meperidine for control of postoperative shivering [13]. In a 
clinical trial on 50 patients undergoing orthopedic surgery, 
the time for control of shivering after surgery with tramadol 
was faster than meperidine and arterial oxygen saturation in 
trmadol group was significantly higher than in the 
meperidine group [32].  
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Table 1- Baseline characteristics and clinical data 




Systolic blood pressure (mmHg) 
Diastolic blood pressure (mmHg) 
Respiratory rate  
Arterial O2 saturation 
Upper sensory spread of spinal anesthesia (T4) 




























Table 2- Comparison of variables at 5, 10 and 30 minutes after administration of tramadol and meperidine for treatment 
of post spinal shivering 
Variables Time Tramadol Group Meperidine Group P Value 
Sedation score (mean) 
 
 
3 min 10±2 18±2 0.051 
10 min 11±3 18±4 
30 min 10±4 16±4 
Systolic blood pressure (mean) 
 
3 min 103.8±7.4 109.7±7.8 0.28 
10 min 105±10.2 110±8.4 
30 min 104±8.6 108±10.2 
Diastolic blood pressure (mean) 
 
 
3 min 64.6±6.8 67.7±8 0.28 
10 min 75.2±4.2 72.8±4.4 
30 min 74.2±6.4 72.6±6.8 
Heart rate (mean) 
 
 
3 min 90.8±15.1 102.3±17.6 <0.001 
10 min 95.4±12.8 105±14.6 
30 min 92.5±10.4 104±15.7 
Respiratory rate (mean) 
 
 
3 min 14.6±1.78 13.1±1.25 <0.001 
10 min 14.8±2.6 12.6±1.8 
30 min 14.6±2.4 12.8±2 
Arterial O2 saturation (mean) 
 
 
3 min 97.2±1.5 95.7±1.52 <0.001 
10 min 98.2±1.8 94.2±1.64 
30 min 98.4±1.2 94.6±1.24 
Nausea and vomiting Within 30 min 4 (11.4%) 19 (54.3%) <0.001 
Pruritus Within 30 min Zero 1 (2.9%) 0.51 
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In another study, the effects of amitriptyline, meperidine 
and tramadol in the treatment of shivering after epidural 
anesthesia in pregnant women were investigated. It was 
found that tramadol and meperidine were better than 
amitriptyline in the treatment of shivering,but the respiratory 
depression risk was greater with meperidine and nausea and 
vomiting were similar between the two groups [33]. 
However, in a clinical trial on 40 patients who were 
shivering after spinal anesthesia, the patients were randomly 
divided into two groups receiving 0.5mg/kg meperidine or 
0.5mg/kg tramadol after shivering. Results showed that 
response to treatment was similar in both groups, and also, 
there was not significant difference in respiratory index, 
level of consciousness, nausea and vomiting between the 
two groups [34]. Tramadol's mechanism of action in the 
treatment of shivering is not clearly known. About the 
mechanisms of tramadol in shivering control it can be noted 
that it has its effect through inhibition of norepinephrine and 
dopamine and thus facilitates the release of serotonin [16]. 
Tramodol is a racemic mixture composed of two isomers, R 
and L having different activity spectrum. The R isomer 
showed weak 5-OH triptamine inhibition re-uptake of 
noradrenaline and increased its excertion. But, the L isomer 
strongly inhibits re-uptake of noradrenaline [35-36]. 
Difference in their performance supports the view that the 
effect of tramadol in the elimination of shivering may be 
related to noradrenergic activity. In our study, systolic and 
diastolic arterial blood pressures were similar between the 
two groups, but heart rate, arterial oxygen saturation, 
respiratory rate and nausea and vomiting were significantly 
different between the two groups. It was shown that 
tramadol with doses of 0.5-1 mg/kg prevented post 
anesthetic shivering and did not affect on the arterial blood 
pressure [37]. Moreover, previous studies identified that use 
of 1 mg/kg tramadol for the treatment of shivering after 
epidural and general anesthesia showed no clear change in 
the heart rate [38-39]. It was shown that the most important 
problem in tramadol use was nausea and vomiting [36]. 
Previous studies that evaluated the efficacy of tramadol in 
the treatment of post anesthesia shivering observed that 
nausea and vomiting increased with 1 and 2 mg/kg tramadol, 
but the number of nausea and vomiting cases reduced 
through slow infusion application [37-40]. Our study 
observed that nausea and vomiting were less in tramadol 
compared to meperidine group. The reasons for this 
observation were the use 0.5 mg/kg tramadol and also slow 
infusion of tramadol in our study. In conclusion, tramadol in 
a dose of 0.5 mg/kg is a more effective agent for the 
treatment of post spinal shivering than meperidine 0.5 
mg/kg, and it is not associated with hemodynamic 
disturbances, excessive sedation or other side-effects and 
could be recommended in parturients who shiver after spinal 
anesthesia. 
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